Investors in Health

Certainly! At GO CAPITAL, we manage seed capital and venture capital investment funds totaling more than €200 million. Our focus is on supporting innovative technology companies based in Western and Central France. Since our inception, we have financed more than 100 innovative companies, reflecting our commitment to driving forward responsible and ambitious projects. We aim to strengthen territorial proximity and promote the creation of local jobs as part of our mission to accelerate the sustainable transformation of territories through seed and venture capital investments. As leaders in technology investment, we harness our expertise to support responsible innovation for a sustainable and prosperous future.

Kurma Partners is a leading European venture capital group specializing in healthcare, managing €470 million in assets. Our firm operates through two dedicated franchises: Kurma Biofund, which focuses on therapeutics (currently active with fund KBIII), and Kurma Diagnostics, which focuses on diagnostic and digital health (currently active with fund Kurma Dx2). We are committed to supporting innovation in healthcare by investing in promising companies that are poised to make significant advancements in therapeutic treatments and diagnostic technologies.

MAIF Avenir is an early-stage venture capital company that is socially and environmentally engaged and civic-minded. We accompany technological organizations on their mission. Our goal is to build, over the long term, a straightforward, honest discourse and impeccable ethics, ensuring that our common interests are aligned.A

North-East was established in 2013 in Copenhagen by Winnie Liljeborg and Per Algot Enevoldsen, the founders of the global jewelry brand, Pandora. Today they, together with their son, Christian Algot Enevoldsen, are the owners of the family office. The purpose of North-East Family Office is to assist the families in preserving their material and ethical values for the benefit and enjoyment of future generations.

At Rockaway Ventures, we are dedicated to supporting early-stage founders who are driving innovation and disrupting traditional industries. Our focus is on Seed to Series A stage startups, with a core emphasis on the Central and Eastern Europe (CEE) and Central European countries of Germany, Austria, and Switzerland (DACH) but considering opportunities across the world.

Nextech is a global, cancer therapeutics-focused venture capital firm headquartered in Zurich, Switzerland. We focus almost exclusively on oncology therapeutics, and on helping to drive value creation for our portfolio companies. We invest in the most promising drug discovery companies with the potential to create multiple medicines. Our portfolio is focused throughout the US and Europe with investments from company inceptions to crossover rounds. Finding and fueling tomorrow's advances in precision medicine.

We invest in Nordic ventures at the pre-seed and seed stages. We see opportunities across sectors, but look for growing categories, and disruptive business models.We look for outstanding founder teams with complementary skill sets. Being a strong founder doesn't mean you excel at everything, but it does mean that you know your strengths and weaknesses. Our structural setup allows us the flexibility to dip our toes via sensible initial investments in founders that are still finding their footing and then do significant follow-up investments when the time is right. We love to collaborate with people who can contribute positively to the success of our startups. We firmly believe this is a strength, and are proud of the results we see among our portfolio founders and the teams they build.

Healthcare & Technology Venture Capital since 2001. Vi Partners is the longest-established Swiss Venture Capital firm. For more than 20 years, Vi Partners has been supporting innovative Technology and Healthcare companies, investing over CHF 330m in 66 startups. Vi Partners-managed funds are backed by Switzerland's most visible companies and institutions, including ETH Zurich, ABB, Buhler, Credit Suisse, Hilti, McKinsey, Nestlé, Schindler, Sulzer, Suva and ZKB as well as the European Investment Fund and many other institutional investors.

Nordic Impact Funds is to improve quality of life for low income people by capitalizing enterprises with social impact.Nordic Impact Funds is a private equity firm dedicated to creating a positive impact in East Africa by leveraging Nordic governance, capital, technology, and expertise. With a focus on improving the quality of life and creating opportunities for jobs.

Alpana Ventures is a Swiss VC focusing on digital transformation. Since 2016 we backed 46 founders' teams, supporting them in their journey towards a positive impact. Committed to value creation, we discover deep tech solutions in Switzerland, Europe and the US. We invest to embed them into innovative business models and back them to become global market leaders. Applying ESG criteria, our portfolio companies help create a more sustainable future.

Endeavour Vision is a leading venture capital and growth equity advisory firm focusing on commercial-stage medtech and digital health companies. We support transformative healthcare technologies that provide superior clinical benefits for patients or bring significant efficiencies to health systems. Our team offers strategic and operational expertise and extensive international experience investing in companies in Europe and North America. We have a proven track record of successful exits with recently realized investments that include Relievant Medsystems, Vertiflex, and Symetis, as well as several IPOs. Endeavour Vision's international investment teams are located in Geneva, Switzerland, Minneapolis, US and San Francisco, US.

Focusing on ICT ventures with a strong growth potential.Dico is a venture capital firm investing in top SaaS companies, driving growth through strategic initiatives like business development and acquisitions.